We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cigna (CI) Inks Deal With CHSS to Enhance Specialty Care
Read MoreHide Full Article
The Cigna Group’s (CI - Free Report) subsidiary, Evernorth Health Services, recently announced its partnership with CarepathRx Health System Solutions (“CHSS”). This partnership will bring together Evernorth’s care and specialty expertise and CHSS’ infusion and pharmacy management qualities to better serve patients with complex care needs.
This move resonates well with Cigna’s ideology to accelerate and enhance the delivery of comprehensive and meaningful solutions to create value for healthcare providers. Moreover, this partnership will help with specialty pharmacy care delivery and boost Cigna’s top line. Pharmacy revenues accounted for the majority of revenues in the first quarter of 2023, and this is expected to rise in the future due to the CarepathRx deal.
The company’s Evernorth segment is set to keep improving on the back of retaining, expanding and winning new relationships. This demonstrates the value and quality of services Evernorth offers. Evernorth’s specialty care contributed 40% to the company’s total revenues and is expected to rise with increasing demand and partnerships. Evernorth’s care represents a significant growth opportunity as the need for virtual care and behavioral health services becomes more prevalent than before.
Evernorth’s union with CHSS will aid more than 600 hospitals, physicians and medical systems in diversifying the services offered for better treatment of patients. Services like virtual care capabilities, coordinated infusion services and value-based care will enhance the quality of service offered to patients.
As specialty care remains a focal point for hospitals, health systems and physicians, Evernorth’s collaboration with CHSS is a stepping stone to bring about more patient care services, thus improving overall outcomes. Evernorth’s minority investment is expected to close by the late second quarter or early third quarter this year.
Price Performance
Shares of Cigna have gained 3% in the past month against the industry’sdecline of 3.6%.
Assurant’s earnings surpassed estimates in three of the last four quarters and missed the mark once, the average surprise being 18.2%. The Zacks Consensus Estimate for AIZ’s 2023 earnings suggests an improvement of 25%, while the same for revenues suggests growth of 2.7% from the respective year-ago reported figures. The consensus mark for AIZ’s 2023 earnings has moved 24.4% north in the past 30 days.
The bottom line of American International outpaced estimates in three of the trailing four quarters and missed the mark once, the average surprise being 9.2%. The Zacks Consensus Estimate for AIG’s 2023 earnings is pegged at $6.58 per share, suggesting growth of 44.6% from the respective year-ago reported figures. The same for revenues suggests an improvement of 8.5% from the prior-year actual. The consensus mark for AIG’s 2023 earnings has moved 0.6% north in the past seven days.
Old Republic’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 29.9%. The Zacks Consensus Estimate for ORI’s 2023 earnings is pegged at $2.4 per share. The same for revenues is pegged at $7.6 billion for 2023.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Cigna (CI) Inks Deal With CHSS to Enhance Specialty Care
The Cigna Group’s (CI - Free Report) subsidiary, Evernorth Health Services, recently announced its partnership with CarepathRx Health System Solutions (“CHSS”). This partnership will bring together Evernorth’s care and specialty expertise and CHSS’ infusion and pharmacy management qualities to better serve patients with complex care needs.
This move resonates well with Cigna’s ideology to accelerate and enhance the delivery of comprehensive and meaningful solutions to create value for healthcare providers. Moreover, this partnership will help with specialty pharmacy care delivery and boost Cigna’s top line. Pharmacy revenues accounted for the majority of revenues in the first quarter of 2023, and this is expected to rise in the future due to the CarepathRx deal.
The company’s Evernorth segment is set to keep improving on the back of retaining, expanding and winning new relationships. This demonstrates the value and quality of services Evernorth offers. Evernorth’s specialty care contributed 40% to the company’s total revenues and is expected to rise with increasing demand and partnerships. Evernorth’s care represents a significant growth opportunity as the need for virtual care and behavioral health services becomes more prevalent than before.
Evernorth’s union with CHSS will aid more than 600 hospitals, physicians and medical systems in diversifying the services offered for better treatment of patients. Services like virtual care capabilities, coordinated infusion services and value-based care will enhance the quality of service offered to patients.
As specialty care remains a focal point for hospitals, health systems and physicians, Evernorth’s collaboration with CHSS is a stepping stone to bring about more patient care services, thus improving overall outcomes. Evernorth’s minority investment is expected to close by the late second quarter or early third quarter this year.
Price Performance
Shares of Cigna have gained 3% in the past month against the industry’sdecline of 3.6%.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
Cigna currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the insurance space are Assurant, Inc. (AIZ - Free Report) , American International Group, Inc. (AIG - Free Report) and Old Republic International Corporation (ORI - Free Report) . Each of these companies currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Assurant’s earnings surpassed estimates in three of the last four quarters and missed the mark once, the average surprise being 18.2%. The Zacks Consensus Estimate for AIZ’s 2023 earnings suggests an improvement of 25%, while the same for revenues suggests growth of 2.7% from the respective year-ago reported figures. The consensus mark for AIZ’s 2023 earnings has moved 24.4% north in the past 30 days.
The bottom line of American International outpaced estimates in three of the trailing four quarters and missed the mark once, the average surprise being 9.2%. The Zacks Consensus Estimate for AIG’s 2023 earnings is pegged at $6.58 per share, suggesting growth of 44.6% from the respective year-ago reported figures. The same for revenues suggests an improvement of 8.5% from the prior-year actual. The consensus mark for AIG’s 2023 earnings has moved 0.6% north in the past seven days.
Old Republic’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 29.9%. The Zacks Consensus Estimate for ORI’s 2023 earnings is pegged at $2.4 per share. The same for revenues is pegged at $7.6 billion for 2023.